lifestyle.travelshq.com

Author: Catalytic Agency

Ascidian Completes Dose Escalation Portion of Phase 1/2 STELLAR Trial of ACDN-01 for Stargardt Disease and Announces Expanded Clinical Study Plans

May 4, 2026
Ascidian to Highlight Progress of Lead Program in Stargardt and Platform Advancements Across Therapeutic Areas at ASGCT 2026 Annual Meeting

April 28, 2026
Apple Tree Partners Initiates Voluntary U.S. Chapter 11 Cases in Delaware to Restructure Operations

December 11, 2025